APO-ALENDRONATE 10 MG — DIN 02248728
ALENDRONIC ACID (ALENDRONATE SODIUM) : 10 MG · APOTEX INC · TABLET · wholesale supply in Canada
Health Canada status: DORMANT
What is APO-ALENDRONATE?
APO-ALENDRONATE 10 MG contains ALENDRONIC ACID (ALENDRONATE SODIUM) : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02248728, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 16-Mar-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
What is APO-ALENDRONATE used for?
APO - ALENDRONATE (alendronate sodium) is indicated for the treatment of osteoporosis in postmenopausal women and men, increasing bone mass and preventing fractures. It is also indicated for the prevention of osteoporosis in postmenopausal women at risk and for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women. Additionally, it treats Paget’s disease of bone in men and women.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Alendronic Acid cost around the world?
Alendronic Acid is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Greece publishes a producer price (ex-factory); Morocco publishes a PPV (public price). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 3 | 19 | USD███.██ |
| Greece | producer price (ex-factory) | 18 | 18 | EUR███.██ |
| Australia | ex-manufacturer | 6 | 14 | AUD███.██ |
| Morocco | PPV (public price) | 4 | 4 | MAD███.██ |
55 pack listings across 31 brand entries and 4 price bases, refreshed 08 Sep 2026. Ranges span every Alendronic Acid pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Alendronic Acid in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
30 holders have a Canadian DIN containing Alendronic Acid, across 79 DINs, of which 17 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| ACCORD HEALTHCARE INC | 3 | 3 | ACH-ALENDRONATE | Sourceable in Canada |
| AURO PHARMA INC | 2 | 2 | AURO-ALENDRONATE | Sourceable in Canada |
| LABORATOIRE RIVA INC. | 5 | 1 | RIVA ALENDRONATE, RIVA-ALENDRONATE, RIVA-ALENDRONATE FC | Sourceable in Canada |
| ANGITA PHARMA INC. | 4 | 1 | AG-ALENDRONATE, AG-ALENDRONATE SODIUM | Sourceable in Canada |
| APOTEX INC | 4 | 1 | APO-ALENDRONATE | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 4 | 1 | JAMP ALENDRONATE SODIUM, JAMP-ALENDRONATE | Sourceable in Canada |
| PRO DOC LIMITEE | 4 | 1 | ALENDRONATE-10, ALENDRONATE-40, ALENDRONATE-5, ALENDRONATE-70 | Sourceable in Canada |
| MANTRA PHARMA INC | 3 | 1 | M-ALENDRONATE | Sourceable in Canada |
| NORA PHARMA INC | 3 | 1 | NRA-ALENDRONATE | Sourceable in Canada |
| SANIS HEALTH INC | 3 | 1 | ALENDRONATE | Sourceable in Canada |
| TEVA CANADA LIMITED | 3 | 1 | TEVA-ALENDRONATE | Sourceable in Canada |
| PHARMASCIENCE INC | 2 | 1 | PMS-ALENDRONATE, PMS-ALENDRONATE-FC | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 10 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | APO - ALENDRONATE 5 mg: Available in bottles of 100 and 500, and in unit dose packages of 30. APO - ALENDRONATE 10 mg: Available in bottles of 100 and 500, and in unit dose packages of 30. APO - ALENDRONATE 40 mg: Available in bottles of 100, and in unit dose packages of 30. APO - ALENDRONATE 70 mg: Available in bottles of 100, and in unit dose packages of 4 and 30. |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Alendronic Acid |
|---|---|
| ATC code | M05BA04 |
| AHFS class | 92:24.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02248728 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2248728 |
| Brand name | APO-ALENDRONATE |
| Generic / active ingredient | ALENDRONIC ACID (ALENDRONATE SODIUM) : 10 MG |
| Market authorization holder | APOTEX INC |
| Health Canada schedule | Prescription |
| ATC code | M05BA04 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M05BA |
| Current status | DORMANT |
| Status date | 16-Mar-2021 |
| Original market date | 2004-05-10 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Alendronic Acid in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SANIS HEALTH INC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
17 of 79 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-ALENDRONATE | 70 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | 02381494 |
| ACH-ALENDRONATE | 5 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | 02381478 |
| ACH-ALENDRONATE | 10 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | 02381486 |
| AG-ALENDRONATE SODIUM | 70 MG | TABLET | ANGITA PHARMA INC. | MARKETED | 02506327 |
| ALENDRONATE | 70 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | 02299712 |
| ALENDRONATE | 70 MG | TABLET | SANIS HEALTH INC | MARKETED | 02352966 |
| ALENDRONATE-70 | 70 MG | TABLET | PRO DOC LIMITEE | MARKETED | 02303078 |
| APO-ALENDRONATE | 70 MG | TABLET | APOTEX INC | MARKETED | 02248730 |
| AURO-ALENDRONATE | 10 MG | TABLET | AURO PHARMA INC | MARKETED | 02388545 |
| AURO-ALENDRONATE | 70 MG | TABLET | AURO PHARMA INC | MARKETED | 02388553 |
2 · Same class — other molecules in ATC M05BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Risedronic Acid | AA-RISEDRONATE DR · ACTONEL · ACTONEL DR · APO-RISEDRONATE · +15 more | 40 | 20 | Yes |
| Alendronic Acid | ACCEL-ALENDRONATE · ACH-ALENDRONATE · ACT ALENDRONATE · AG-ALENDRONATE · +31 more | 79 | 17 | Yes |
| Zoledronic Acid | ACLASTA · ACT ZOLEDRONIC ACID · ACT ZOLEDRONIC ACID CONCENTRATE · JAMP-ZOLEDRONIC ACID · +14 more | 26 | 9 | Yes |
| Pamidronic Acid | AREDIA · AREDIA 30MG · AREDIA 90MG · AREDIA LIQ INJ 3MG/ML · +6 more | 23 | 8 | Yes |
| Clodronic Acid | BONEFOS · CLASTEON · OSTAC CAP 400MG | 4 | 1 | Yes |
| Etidronic Acid | ACT ETIDRONATE · APO-ETIDRONATE · DIDRONEL INJ 50MG/ML · DIDRONEL TAB 200MG · +2 more | 9 | 0 | Not in Canada |
| Ibandronic Acid | BONDRONAT | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M05B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M05BX | Burosumab · Denosumab · Romosozumab | 9 | 8 |
| M05BB | Alendronic Acid And Cholecalciferol · Etidronic Acid And Calcium, Sequential · Risedronic Acid And Calcium, Sequential · Risedronic Acid, Calcium And Cholecalciferol, Sequential | 22 | 6 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is APO-ALENDRONATE called?
The same molecule, Alendronic Acid, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Fosamax Plus | Latin | Australia |
| Alendronate Sandoz | Latin | Australia |
| ALENDRONATE-WGR | Latin | Australia |
| Fonat | Latin | Australia |
| ACIDE ALENDRONIQUE GT | Latin | Morocco |
| FOSAMAX | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.